ClinicalTrials.gg
Enrolling by invitationNCT07404384Breath-fibroUpdated Feb 11, 2026

Slow Breathing and Resistance Exercise in Fibromyalgia

An interventional study of Slow Breathing with Visual Pacer and Slow Breathing without Visual Pacer in Fibromyalgia and Fibromyalgia Syndrome, sponsored by University of Malaga. Enrolling by invitation at 2 sites in Spain. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-11.

Sponsored by University of Malaga · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Apr 2026, 7 months ago, but the record still lists the study as enrolling by invitation.
Phase
Not applicable
Study type
Interventional
Enrollment
159
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This randomized controlled trial investigates whether slow breathing techniques influence heart rate variability, exercise self-efficacy, and resistance exercise performance in women with fibromyalgia. Participants will be randomly assigned to one of three breathing conditions (slow breathing with visual pacer, slow breathing without pacer, or spontaneous breathing) before performing a biceps curl resistance exercise. The study will examine how breathing patterns interact with psychological variables (anxiety sensitivity, pain catastrophizing, pain hypervigilance, and kinesiophobia) to affect physiological and performance outcomes.

Read the detailed description

Background: Fibromyalgia is considered one of the most representative central sensitivity syndromes, where central sensitization is the predominant characteristic. Resistance and strength training have demonstrated efficacy as therapeutic strategies for fibromyalgia patients. Slow breathing has been shown to reduce anxiety, perceived stress, and pain intensity while increasing heart rate variability (HRV), a biomarker of stress reactivity. The Fear-Avoidance Model of Pain demonstrates that anxiety sensitivity, pain catastrophizing, hypervigilance, and fear of pain/movement largely determine activity levels in chronic pain patients. However, no studies have examined how slow breathing interacts with these psychological variables to enhance resistance exercise performance in fibromyalgia patients.

Study Design: Single-session, three-arm randomized controlled trial with parallel group assignment.

Experimental Procedure:

Phase 1 - Baseline Assessment:

  • Semi-structured interview for demographic and clinical information
  • Administration of self-report questionnaires (detailed below)
  • 5-minute baseline HRV measurement (seated, eyes open, spontaneous breathing)
  • Respiration rate inferred from HRV

Phase 2 - Resistance Exercise Preparation:

  • Determination of optimal weight for biceps curl exercise using submaximal protocol
  • Warm-up: 3 minutes walking + 10 unloaded practice repetitions
  • Progressive weight testing to determine 50% 1-RM equivalent

Phase 3 - Breathing Intervention (8 minutes): Participants randomly assigned to:

  • Condition A: Slow breathing with visual pacer (6 breaths/min: 4-sec inhale, 6-sec exhale) displayed continuously
  • Condition B: Slow breathing without pacer (same pattern, brief training then self-paced)
  • Condition C: Spontaneous breathing at participant's natural rate
  • HRV continuously recorded during all breathing conditions. Respiration rate inferred from HRV.

Phase 4 - Resistance Exercise Test:

  • Biceps curl exercise at 50% estimated 1-RM
  • Maximum repetitions to voluntary exhaustion
  • Proper form maintained (back against wall, arms close to body, full range of motion)

Phase 5 - Post-Exercise Assessment:

  • Immediate measurement of dependent variables (detailed below)
  • 8 min. of rest
  • HRV recording 5 min.

Safety Monitoring: Continuous observation by trained evaluators; clear stopping criteria.

02

Conditions studied

  • Fibromyalgia
  • Fibromyalgia Syndrome

Keywords

  • Slow Breathing
  • Diaphragmatic Breathing
  • Heart Rate Variability
  • Resistance Exercise
  • Fear-Avoidance Model
  • Central Sensitivity Syndrome
  • Exercise Performance
  • Pain Catastrophizing
  • Kinesiophobia
03

In context

Fibromyalgia

1,243 studies on the registry are indexed under Fibromyalgia; 256 are open to participants now.

This study's planned enrollment of 159 is above the median of 60 across 937 interventional studies indexed under Fibromyalgia.

Browse Fibromyalgia studies →

Lead sponsor

University of Malaga is the lead sponsor of 121 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Female sex
  2. Age ≥ 18 years
  3. Medical diagnosis of fibromyalgia confirmed by physician
  4. Capacity to understand and sign form
  5. Fluency in spoken and written Spanish

Exclusion criteria

Exclusion Criteria:

  1. Current or past severe mental illness or neurodegenerative disease
  2. Current treatment for oncological pathology, degenerative disease, or terminal illness
  3. Musculoskeletal injury contraindicating biceps curl exercise
  4. Connective tissue disease or arthritis
  5. Inability to perform biceps curl exercise due to physical limitations
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
159 participants (estimated)

Study arms

  • Experimental
    Slow Breathing with Visual Pacer

    Participants perform 8 minutes of paced slow breathing (6 breaths/min) with continuous visual guidance before resistance exercise test.

    Behavioral: Slow Breathing with Visual Pacer

  • Experimental
    Slow Breathing without Visual Pacer

    Participants perform 8 minutes of self-paced slow breathing (6 breaths/min target) after brief training, without continuous visual guidance, before resistance exercise test.

    Behavioral: Slow Breathing without Visual Pacer

  • Experimental
    Spontaneous Breathing

    Participants breathe naturally at their spontaneous rate for equivalent duration before resistance exercise test.

    Behavioral: Spontaneous Breathing (Active Control)

Interventions

  • BehavioralSlow Breathing with Visual Pacer

    Participants receive brief training using a visual pacer displayed on computer screen showing a line that rises during inhalation and falls during exhalation. The pacing is set to 6 respiratory cycles per minute (4 seconds inhalation, 6 seconds exhalation). Participants place one hand below chest and abdomen to monitor diaphragmatic movement. After training, participants continue slow breathing with the visual pacer continuously displayed, maintaining the prescribed respiratory rate.

  • BehavioralSlow Breathing without Visual Pacer

    Participants receive identical brief training using the visual pacer to learn the slow breathing pattern (6 cycles per minute: 4 seconds inhalation, 6 seconds exhalation). Hand placement below chest and abdomen to monitor diaphragmatic movement. After training, the visual pacer is removed and participants attempt to maintain the slow breathing pattern independently without external guidance.

  • BehavioralSpontaneous Breathing (Active Control)

    Participants spend equivalent time breathing at their natural, spontaneous rate. They receive similar attention from evaluators but no specific breathing instructions. Participants are instructed to breathe normally at their usual pace and rhythm.

06

What researchers measure

Primary outcomes

  1. Heart Rate Variability (HRV) - Change from Baseline

    Root mean square of successive differences (RMSSD) in milliseconds

    Time frame: Measured: 5 min baseline, 8 min during breathing intervention, and 5 min post-exercise recovery.

  2. Number of Biceps Curl Repetitions

    Number of properly executed biceps curl repetitions at 50% estimated 1-RM performed to voluntary exhaustion with proper form maintained.

    Time frame: Immediately during the resistance exercise test (single session).

Secondary outcomes

  1. Exercise-Related Self-Efficacy

    Single-item 0-10 numeric rating scale.

    Time frame: Immediately post-exercise.

  2. Fatigue

    Borg Rating Of Perceived Exertion. Rating of perceived exertion is an outcome measure scale used to gauge one's exercise intensity without the need to rely on physiological parameters. The scale rates exertion from a scale of 6 (no exertion) to 20 (maximum effort).

    Time frame: Immediately post-exercise

  3. Change in Current Pain Intensity

    Numeric Rating Scale (NRS) 0-10

    Time frame: Immediately post-exercise

  4. Change in Anxiety

    Numeric Rating Scale (NRS) 0-10

    Time frame: Immediately post-exercise.

  5. Perceived effort required to do the biceps exercise

    Numeric Rating Scale (NRS) 0-10.

    Time frame: Immediately post-exercise

  6. Breathing Difficulty

    Numeric Rating Scale (NRS) 0-10

    Time frame: Immediately after breathing intervention.

07

Study locations

2 sites
  • Asociación de Fibromialgia y Síndrome de Fatiga Crónica de Málaga (AFIBROMA)
    Málaga, Málaga 29010, Spain
  • Asociación de Pacientes de Fibromialgia y Síndrome de Fatiga Crónica de Málaga (APAFIMA)
    Málaga, Málaga 29010, Spain
08

References and documents

Publications

  • Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 2008 Jun;37(6):339-52. doi: 10.1016/j.semarthrit.2007.09.003. Epub 2008 Jan 14. PubMed 18191990 ↗
  • Rogers AH, Farris SG. A meta-analysis of the associations of elements of the fear-avoidance model of chronic pain with negative affect, depression, anxiety, pain-related disability and pain intensity. Eur J Pain. 2022 Sep;26(8):1611-1635. doi: 10.1002/ejp.1994. Epub 2022 Jul 7. PubMed 35727200 ↗
  • Bamert M, Inauen J. Physiological stress reactivity and recovery: Some laboratory results transfer to daily life. Front Psychol. 2022 Aug 15;13:943065. doi: 10.3389/fpsyg.2022.943065. eCollection 2022. PubMed 36046406 ↗
  • da Silva JM, de Barros BS, Almeida GJ, O'Neil J, Imoto AM. Dosage of resistance exercises in fibromyalgia: evidence synthesis for a systematic literature review up-date and meta-analysis. Rheumatol Int. 2022 Mar;42(3):413-429. doi: 10.1007/s00296-021-05025-9. Epub 2021 Oct 15. PubMed 34652480 ↗
  • Goheen J, Anderson JAE, Zhang J, Northoff G. From Lung to Brain: Respiration Modulates Neural and Mental Activity. Neurosci Bull. 2023 Oct;39(10):1577-1590. doi: 10.1007/s12264-023-01070-5. Epub 2023 Jun 7. PubMed 37285017 ↗
  • Andrade A, de Azevedo Klumb Steffens R, Sieczkowska SM, Peyre Tartaruga LA, Torres Vilarino G. A systematic review of the effects of strength training in patients with fibromyalgia: clinical outcomes and design considerations. Adv Rheumatol. 2018 Oct 22;58(1):36. doi: 10.1186/s42358-018-0033-9. PubMed 30657077 ↗

Individual participant data

Plan to share: Yes — We will share the joint database through a web link for public access.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2026; primary completion for Apr 2026, 2 months later.

Of 436 non-industry interventional studies with no phase under Fibromyalgia, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's planned 2 months is below that.

Counting every sponsor, half of 449 studies reached it within 15 months; a quarter within 6 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 4, 2026
First posted
Feb 11, 2026
StartEst.
Feb 2026
Primary completionEst.
Apr 2026
CompletionEst.
May 2027
Last update
Feb 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07404384
Collaborators
Asociación de Pacientes de Fibromialgia y Síndrome de Fatiga Crónica de Málaga (APAFIMA), Asociación de Fibromialgia y Síndrome de Fatiga Crónica de Málaga (AFIBROMA)
Responsible party
Elena R. Serrano-Ibáñez (Principal Investigator, University of Malaga) — Principal investigator
First posted
Feb 11, 2026
Start date
Feb 2026 (estimated)
Primary completion
Apr 2026 (estimated)
Completion
May 2027 (estimated)
Last update
Feb 11, 2026

Study contacts

Marcin Czub, PhD
principal investigator · University of Wrocław
Rosa Esteve, PhD
principal investigator · University of Malaga
Elena R. Serrano-Ibáñez, PhD
principal investigator · University of Malaga
Joanna Piskorz, PhD
principal investigator · University of Wrocław

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion